State Street’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $376M | Buy |
710,895
+28,666
| +4% | +$13.2M | 0.01% | 702 |
|
|
2026
Q1 | $328M | Buy |
682,229
+17,336
| +3% | +$8.88M | 0.01% | 716 |
|
|
2025
Q4 | $373M | Sell |
664,893
-8,248
| -1% | -$4.68M | 0.01% | 650 |
|
|
2025
Q3 | $346M | Sell |
673,141
-33,636
| -5% | -$14.7M | 0.01% | 681 |
|
|
2025
Q2 | $222M | Sell |
706,777
-76,209
| -10% | -$22.9M | 0.01% | 832 |
|
|
2025
Q1 | $239M | Buy |
782,986
+3,172
| +0.4% | +$1.07M | 0.01% | 793 |
|
|
2024
Q4 | $259M | Buy |
779,814
+26,857
| +4% | +$9.11M | 0.01% | 777 |
|
|
2024
Q3 | $251M | Buy |
752,957
+50,312
| +7% | +$19.1M | 0.01% | 788 |
|
|
2024
Q2 | $289M | Buy |
702,645
+5,686
| +0.8% | +$2.25M | 0.01% | 676 |
|
|
2024
Q1 | $282M | Buy |
696,959
+25,814
| +4% | +$9.08M | 0.01% | 698 |
|
|
2023
Q4 | $206M | Buy |
671,145
+25,287
| +4% | +$6.83M | 0.01% | 824 |
|
|
2023
Q3 | $156M | Sell |
645,858
-26,018
| -4% | -$6.65M | 0.01% | 900 |
|
|
2023
Q2 | $161M | Sell |
671,876
-169,316
| -20% | -$35.2M | 0.01% | 921 |
|
|
2023
Q1 | $158M | Buy |
841,192
+11,372
| +1% | +$2.35M | 0.01% | 894 |
|
|
2022
Q4 | $176M | Buy |
829,820
+8,023
| +1% | +$1.6M | 0.01% | 818 |
|
|
2022
Q3 | $129M | Sell |
821,797
-38,894
| -5% | -$6.21M | 0.01% | 955 |
|
|
2022
Q2 | $129M | Sell |
860,691
-39,164
| -4% | -$5.67M | 0.01% | 1001 |
|
|
2022
Q1 | $147M | Buy |
899,855
+21,868
| +2% | +$3.61M | 0.01% | 1034 |
|
|
2021
Q4 | $191M | Buy |
877,987
+13,606
| +2% | +$2.85M | 0.01% | 885 |
|
|
2021
Q3 | $164M | Buy |
864,381
+15,688
| +2% | +$2.86M | 0.01% | 948 |
|
|
2021
Q2 | $150M | Buy |
848,693
+19,371
| +2% | +$3.34M | 0.01% | 1021 |
|
|
2021
Q1 | $136M | Sell |
829,322
-32,781
| -4% | -$5.01M | 0.01% | 1006 |
|
|
2020
Q4 | $120M | Buy |
862,103
+19,876
| +2% | +$2.51M | 0.01% | 1007 |
|
|
2020
Q3 | $94.1M | Sell |
842,227
-19,817
| -2% | -$2.29M | 0.01% | 1002 |
|
|
2020
Q2 | $80.2M | Buy |
862,044
+2,426
| +0.3% | +$206K | 0.01% | 1121 |
|
|
2020
Q1 | $63.1M | Buy |
859,618
+62,312
| +8% | +$5.41M | 0.01% | 1096 |
|
|
2019
Q4 | $67M | Buy |
797,306
+4,993
| +0.6% | +$386K | ﹤0.01% | 1326 |
|
|
2019
Q3 | $66.6M | Buy |
792,313
+2,609
| +0.3% | +$197K | 0.01% | 1248 |
|
|
2019
Q2 | $51.7M | Buy |
789,704
+96,499
| +14% | +$5.56M | ﹤0.01% | 1469 |
|
|
2019
Q1 | $40.9M | Sell |
693,205
-52,447
| -7% | -$3.13M | ﹤0.01% | 1567 |
|
|
2018
Q4 | $39.5M | Buy |
745,652
+235,225
| +46% | +$12.9M | ﹤0.01% | 1503 |
|
|
2018
Q3 | $30.6M | Buy |
510,427
+207,890
| +69% | +$11.4M | ﹤0.01% | 1877 |
|
|
2018
Q2 | $13M | Buy |
302,537
+76,880
| +34% | +$3.11M | ﹤0.01% | 2413 |
|
|
2018
Q1 | $7.87M | Buy |
225,657
+86,029
| +62% | +$3.14M | ﹤0.01% | 2579 |
|
|
2017
Q4 | $5.06M | Buy |
139,628
+8,404
| +6% | +$295K | ﹤0.01% | 2785 |
|
|
2017
Q3 | $4.19M | Sell |
131,224
-1,507
| -1% | -$46K | ﹤0.01% | 2880 |
|
|
2017
Q2 | $3.85M | Buy |
132,731
+5,209
| +4% | +$146K | ﹤0.01% | 2868 |
|
|
2017
Q1 | $3.81M | Sell |
127,522
-2,077
| -2% | -$67K | ﹤0.01% | 2835 |
|
|
2016
Q4 | $4.68M | Buy |
129,599
+39,824
| +44% | +$1.33M | ﹤0.01% | 2727 |
|
|
2016
Q3 | $2.68M | Buy |
+89,775
| New | +$2.62M | ﹤0.01% | 2855 |
|
Other funds holding MEDP
WA
State Street's MEDP Position: Q2 2026 in Review
State Street increased its Medpace (MEDP) stake by 4.2% in Q2 2026, buying an estimated $13.2M and bringing the position to 710,895 shares worth $376M. The position accounts for 0.01% of the portfolio, ranked #702.
State Street first reported a position in MEDP in Q3 2016 and has held it in 40 quarters since. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- State Street held 710,895 shares of Medpace worth $376M as of Q2 2026.
- State Street bought 28,666 Medpace shares in Q2 2026, an estimated $13.2M.
- Medpace made up 0.01% of State Street's portfolio in Q2 2026, its #702 holding.
- State Street first reported a position in Medpace in Q3 2016 and has held it in 40 quarters since.
- 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.